US Broker Ratings

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Exploring a Promising 183% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX) is capturing the attention of investors with a compelling proposition: a potential upside of 183.07%. As a commercial-stage biopharmaceutical company based in Australia, Telix is..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Unveiling a 32.77% Potential Upside for Investors

Thermo Fisher Scientific Inc (NYSE: TMO) stands as a pivotal player in the healthcare sector, carving out a niche within the diagnostics and research industry. With a market capitalization of..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: A Look at Its 9.08% Potential Upside

For investors looking to delve into the healthcare sector, Zimmer Biomet Holdings, Inc. (NYSE: ZBH) presents an intriguing opportunity. With a market capitalization of $18.65 billion, this U.S.-based medical device..

Molina Healthcare Inc (MOH) Stock Analysis: Navigating Healthcare with a 7.76% Upside Potential

Molina Healthcare Inc (NYSE: MOH), a prominent player in the healthcare plans industry, offers a compelling investment narrative for those looking to capitalize on the growing need for managed healthcare..

Waystar Holding Corp. (WAY) Stock Analysis: A 43.91% Upside Potential in Health Information Services

Waystar Holding Corp. (NASDAQ: WAY) has emerged as a formidable player in the healthcare sector, specifically within the burgeoning health information services industry. With a market capitalization of $4.93 billion,..

Bruker Corporation (BRKR) Stock Analysis: Unlocking a 32% Potential Upside Amidst Volatile Metrics

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, particularly in the medical devices industry, stands out with a market capitalization of $5.58 billion. Headquartered in Billerica, Massachusetts,..

DaVita Inc. (DVA) Stock Analysis: Navigating the Healthcare Sector with Robust Returns

DaVita Inc. (NYSE: DVA), a leading provider of kidney dialysis services in the United States, presents a compelling case for investors intrigued by the healthcare sector. With a market capitalization..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Potential Upside of 22.82% Signals Strong Growth Prospects

Teva Pharmaceutical Industries (NYSE: TEVA), a stalwart in the global healthcare sector, presents a compelling opportunity for investors with its promising growth potential. The company, headquartered in Israel, is a..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking a 65% Potential Upside

Investors eyeing opportunities in the healthcare sector might find Stevanato Group S.p.A. (NYSE: STVN) an intriguing prospect. Headquartered in Piombino Dese, Italy, Stevanato operates at the cutting edge of the..

Teleflex Incorporated (TFX) Stock Analysis: A Healthcare Innovator with a 17.57% Potential Upside

Teleflex Incorporated (TFX), a dominant player in the medical instruments and supplies industry, continues to showcase its prowess with a diverse range of innovative medical devices. Based in Wayne, Pennsylvania,..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 33.91% Potential Upside for Investors

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare sector, stands as a beacon of stability and growth potential for investors looking to capitalize on the robust dynamics..

Qiagen N.V. (QGEN) Stock Analysis: Understanding Its 23.98% Potential Upside

Investors keeping an eye on the healthcare sector, particularly in diagnostics and research, may find Qiagen N.V. (NYSE: QGEN) an intriguing prospect. With a market capitalization of $9.18 billion, Qiagen..

Johnson & Johnson (JNJ) Stock Analysis: Navigating a Healthcare Titan Amidst a -1.29% Potential Downside

As Johnson & Johnson (NYSE: JNJ) continues to solidify its reputation as a leader in the healthcare sector, investors are keenly evaluating its current and future performance metrics. With a..

Grifols, S.A. (GRFS) Investor Outlook: Exploring a 29% Potential Upside Amidst Strategic Growth

Grifols, S.A. (GRFS), a leading player in the healthcare sector with a specialization in plasma-derived medicines, offers an intriguing opportunity for investors seeking exposure to the drug manufacturing industry. Headquartered..

Revolution Medicines, Inc. (RVMD) Stock Analysis: Capitalizing on a 31.45% Potential Upside in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD) is emerging as a significant player in the biotechnology sector, particularly in the field of precision oncology. With a focus on developing novel targeted therapies..

Encompass Health Corporation (EHC)

⚠️ No article content returned.

..

Pfizer Inc. (PFE) Stock Analysis: Navigating Opportunities Amid a 6.36% Dividend Yield

Pfizer Inc. (NYSE: PFE), the New York-based pharmaceutical giant, commands a prominent position in the healthcare sector with a market capitalization of $153.81 billion. Despite the broad challenges facing the..

West Pharmaceutical Services, Inc. (WST) Stock Analysis: Unlocking a Potential 29.49% Upside

West Pharmaceutical Services, Inc. (NYSE: WST), a key player in the healthcare sector, particularly within the medical instruments and supplies industry, presents a compelling investment opportunity for those seeking growth..

Henry Schein, Inc. (HSIC) Investor Outlook: Explore a 15.7% Upside Potential

Henry Schein, Inc. (NASDAQ: HSIC), a titan in the healthcare sector specializing in medical distribution, stands out with a notable market capitalization of $9.14 billion. Despite a slight dip in..

GSK plc (GSK) Stock Analysis: Exploring a 5.44% Potential Upside in the Healthcare Sector

GSK plc (NYSE: GSK), a titan in the healthcare sector, continues to be a focal point for investors due to its robust product pipeline and global footprint. With a market..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds